Nymox Pharmaceutical ''Buy'' Recommendations In Three Independent Analyst Reports

28 Apr 2006

·www.biospace.com

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--April 28, 2006--Three independent analyst reports have "buy" recommendations for Nymox Pharmaceutical Corporation (NASDAQ: NYMX - News). These include: Dutton Associates (written by Dr. William Prather on March 15, 2006), WallStreet Research (written by Alan Stone on December 22, 2005), and Cohen Independent Research Group (written on December 6, 2005).

Organizations

Independent Research GmbH

Nymox Pharmaceutical Corp.

Indications

Targets

Drugs

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.